South China Morning Post
- Total disclosed deal value in 2022 reached about US$19 billion, surpassing the previous year’s US$17.8 billion record, according to a report by Bain and Company
- The industry shrank drastically in China, however, as pandemic restrictions and geopolitical tensions strangled transactions
Vikram Kapur discusses the Asia-Pacific region’s coming of age for healthcare private equity, in terms of geographical breadth, opportunities across sectors and, on average, cheque sizes continuing to grow.